Sysmex (OTCMKTS:SSMXY) Hits New 1-Year Low - Time to Sell?

Key Points

• Sysmex Corporation (OTCMKTS:SSMXY) has dropped to a new 52-week low, trading at $11.70, down from a previous close of $12.22.
• Analysts have varying ratings on Sysmex, with Zacks upgrading the stock to a "hold" while Goldman Sachs has raised it to a "buy," leading to an average rating of "Moderate Buy".
• The company reported a missed earnings estimate for its last quarter, posting $0.05 EPS compared to the consensus estimate of $0.12, along with a revenue of $717.09 million, below expectations of $807.27 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) reached a new 52-week low during trading on Tuesday . The stock traded as low as $11.70 and last traded at $11.70, with a volume of 11201 shares trading hands. The stock had previously closed at $12.22.

Analyst Ratings Changes

A number of brokerages have issued reports on SSMXY. Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. The Goldman Sachs Group raised shares of Sysmex from a "hold" rating to a "buy" rating in a report on Thursday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Sysmex presently has an average rating of "Moderate Buy".

Sysmex Stock Down 3.6%

The firm has a fifty day simple moving average of $12.98 and a 200-day simple moving average of $15.89. The company has a market capitalization of $7.42 billion, a P/E ratio of 23.56 and a beta of 1.16. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The business had revenue of $717.09 million during the quarter, compared to the consensus estimate of $807.27 million. On average, equities research analysts expect that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.